Endurance Wealth Management, Inc. Novartis Ag Transaction History

Endurance Wealth Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	SELL	$78.07 - $94.43 $22,640 - $27,384	-290 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$82.14 - $91.0 $2,874 - $3,185	-35 Reduced 10.77%	290 $25,000
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $11,872 - $16,633	-168 Reduced 34.08%	325 $27,000
Q4 2019 Jan 14, 2020	BUY	$84.35 - $95.37 $14,170 - $16,022	168 Added 51.69%	493 $47,000
Q3 2019 Oct 18, 2019	SELL	$85.54 - $94.26 $684,320 - $754,080	-8,000 Reduced 96.1%	325 $28,000
Q2 2019 Jul 30, 2019	BUY	$75.4 - $92.8 $603,200 - $742,400	8,000 Added 2461.54%	8,325 $760,000
Q1 2019 May 01, 2019	SELL	$75.32 - $86.15 $301,280 - $344,600	-4,000 Reduced 92.49%	325 $31,000
Q4 2018 Jan 14, 2019	BUY	$73.66 - $82.02 $316,001 - $351,865	4,290 Added 12257.14%	4,325 $371,000
Q2 2018 Aug 02, 2018	SELL	$64.91 - $73.36 $74,646 - $84,364	-1,150 Reduced 97.05%	35 $3,000
Q3 2017 Oct 19, 2017	BUY	$74.14 - $77.27 $87,855 - $91,564	1,185	1,185 $102,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $225B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.